Change to the sampling plan for the reagent vial filling procedure for both devices.
Device | ABBOTT REALTIME HBV |
Classification Name | Hepatitis Viral B Dna Detection |
Generic Name | Hepatitis Viral B Dna Detection |
Applicant | ABBOTT MOLECULAR, INC. |
Date Received | 2013-05-01 |
Decision Date | 2013-05-28 |
PMA | P080026 |
Supplement | S007 |
Product Code | MKT |
Advisory Committee | Microbiology |
Supplement Type | 30-day Notice |
Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier |
Expedited Review | No |
Combination Product | No |
Applicant Address | ABBOTT MOLECULAR, INC. 1300 East Touhy Avenue des Plaines, IL 60018 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P080026 | | Original Filing |
S024 |
2021-02-05 |
30-day Notice |
S023 |
2020-11-16 |
30-day Notice |
S022 |
2019-04-10 |
30-day Notice |
S021 |
2017-06-27 |
135 Review Track For 30-day Notice |
S020 |
2016-12-01 |
30-day Notice |
S019 |
2016-11-16 |
30-day Notice |
S018 |
2016-10-27 |
30-day Notice |
S017 |
2016-03-28 |
30-day Notice |
S016 |
2015-07-29 |
Real-time Process |
S015 | | |
S014 |
2015-03-26 |
30-day Notice |
S013 |
2014-11-10 |
30-day Notice |
S012 |
2014-10-24 |
30-day Notice |
S011 |
2013-11-12 |
30-day Notice |
S010 |
2013-10-21 |
30-day Notice |
S009 |
2013-07-23 |
30-day Notice |
S008 |
2013-07-11 |
Real-time Process |
S007 |
2013-05-01 |
30-day Notice |
S006 |
2013-02-15 |
Normal 180 Day Track |
S005 |
2012-12-26 |
30-day Notice |
S004 |
2012-10-04 |
30-day Notice |
S003 |
2012-04-02 |
135 Review Track For 30-day Notice |
S002 |
2011-07-01 |
135 Review Track For 30-day Notice |
S001 | | |
NIH GUDID Devices